Cyclo Therapeutics, Inc. (CYTH)
NASDAQ: CYTH · IEX Real-Time Price · USD
1.210
+0.010 (0.83%)
At close: Jul 19, 2024, 4:00 PM
1.300
+0.090 (7.44%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Cyclo Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Cyclo Therapeutics stock have an average target of 3.20, with a low estimate of 2.60 and a high estimate of 4.00. The average target predicts an increase of 164.46% from the current stock price of 1.21.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 31, 2024.
Analyst Ratings
The average analyst rating for CYTH stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +147.93% | May 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +147.93% | May 1, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $2.6 | Strong Buy | Initiates | $2.6 | +114.88% | Apr 22, 2024 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $4 | Hold → Strong Buy | Upgrades | $4 | +230.58% | Sep 27, 2023 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 21, 2023 |
Financial Forecast
Revenue This Year
1.38M
from 1.08M
Increased by 28.30%
Revenue Next Year
1.58M
from 1.38M
Increased by 14.19%
EPS This Year
-0.69
from -1.23
EPS Next Year
-0.66
from -0.69
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.6M | 1.9M | 1.9M |
| Avg | 1.4M | 1.6M | 1.9M |
| Low | 1.2M | 1.3M | 1.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 47.1% | 36.4% | 23.0% |
| Avg | 28.3% | 14.2% | 19.5% |
| Low | 9.3% | -7.7% | 14.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.65 | -0.51 | -0.40 |
| Avg | -0.69 | -0.66 | -0.39 |
| Low | -0.73 | -0.78 | -0.37 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.